Euflexxa
Device Orthopedics
General payments
$783,177
Research payments
$147,699
Through program year 2025, $783,177 in general payments and $147,699 in research payments were reported against Euflexxa (Orthopedics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $111,185 | 5,351 |
| 2024 | General | $96,126 | 5,050 |
| 2023 | General | $112,524 | 5,286 |
| 2022 | General | $102,221 | 5,467 |
| 2022 | Research | $36,973 | 1 |
| 2021 | General | $78,534 | 4,376 |
| 2020 | General | $63,746 | 2,540 |
| 2019 | General | $218,841 | 5,712 |
| 2019 | Research | $110,726 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 61 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
33,782 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.